J. Goldman & Co’s Immunomedics Inc IMMU Stock Holding History

J. Goldman & Co’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-90,276	Closed	-$3.2M	–	434
2020 Q2	$3.2M	Buy	+90,276	New	+$2.64M	0.2%	128
2019 Q1	–	Sell	-142,536	Closed	-$2.3M	–	357
2018 Q4	$2.03M	Buy	+142,536	New	+$2.83M	0.16%	141
2017 Q1	–	Sell	-746,000	Closed	-$3.78M	–	447
2016 Q4	$2.74M	Sell	746,000 -950,699	-56%	-$2.81M	0.18%	152
2016 Q3	$5.51M	Buy	+1,696,699	New	+$4.74M	0.31%	92

Other funds holding IMMU

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

J. Goldman & Co's IMMU Position: Q3 2020 in Review

J. Goldman & Co sold out of Immunomedics Inc (IMMU) in Q3 2020, closing a stake of 90,276 shares — an estimated $3.2M sold.

J. Goldman & Co first reported a position in IMMU in Q3 2016 and held it in 4 quarters. The position peaked at $5.51M in Q3 2016. 408 funds tracked by Wall St. Rank hold IMMU as of Q3 2020.

J. Goldman & Co reported no remaining Immunomedics Inc position as of Q3 2020 after selling out during the quarter.
J. Goldman & Co sold 90,276 Immunomedics Inc shares in Q3 2020, an estimated $3.2M.
J. Goldman & Co first reported a position in Immunomedics Inc in Q3 2016 and held it in 4 quarters.
J. Goldman & Co's Immunomedics Inc position peaked at $5.51M in Q3 2016.
408 funds tracked by Wall St. Rank held Immunomedics Inc as of Q3 2020.

Based on J. Goldman & Co's 13F filing for Q3 2020, filed 16 Nov 2020.